T-Cell Select™ - ARCSA Registration 4a3c00551560fc6303a85b6aa5a2d4c8
Access comprehensive regulatory information for T-Cell Select™ in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID 4a3c00551560fc6303a85b6aa5a2d4c8 and manufactured by OXFORD IMMUNOTEC LIMITED. The device was registered on June 09, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
III
4a3c00551560fc6303a85b6aa5a2d4c8
T-Cell Select™
ARCSA ID: 4a3c00551560fc6303a85b6aa5a2d4c8
Device Classification
Risk Class
III
Product Type
In Vitro Diagnostic
Commercial Name
19-041 IVD Reagents/Testing Kits, Serology, Bacteria
Registration Information
Analysis ID
4a3c00551560fc6303a85b6aa5a2d4c8
Registration Date
June 09, 2023
Expiration Date
June 09, 2028
Product Use
INTENDED FOR THE ISOLATION OF WHOLE BLOOD MONONUCLEAR IMMUNE CELLS
Manufacturer
City
ABINGDON
Country
UNITED KINGDOM OF GREAT BRITAIN
Address
143 PARK DRIVE EAST, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4SE, U.K
Product Owner
Name
OXFORD IMMUNOTEC LIMITED
Country
UNITED KINGDOM OF GREAT BRITAIN
Authorized Representative